These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34386082)

  • 1. MicroRNA-1298-5p inhibits the tumorigenesis of breast cancer by targeting E2F1.
    Zhang J; Hu C; Hu D; Fan Z
    Oncol Lett; 2021 Sep; 22(3):660. PubMed ID: 34386082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR-625-5p.
    Shi G; Li H; Chen Y; Chen Z; Lin X
    Thorac Cancer; 2024 Apr; 15(10):808-819. PubMed ID: 38409914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1.
    Li Y; Zeng Q; Qiu J; Pang T; Ye F; Huang L; Zhang X
    J Breast Cancer; 2020 Aug; 23(4):355-372. PubMed ID: 32908787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment.
    Huang C; Ma L; Duan F; Li R; Zhang Y; Wang Y; Luo M; He Z; Luo Z
    Bioengineered; 2021 Dec; 12(1):8020-8030. PubMed ID: 34726120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 7. Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p/MTA1 axis.
    Wang P; Qu H; Wang L; Hu Z
    Thorac Cancer; 2023 Aug; 14(22):2198-2209. PubMed ID: 37349877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.
    Zhang H; Wang M; Lang Z; Liu H; Liu J; Ma L
    Clinics (Sao Paulo); 2022; 77():100115. PubMed ID: 36228497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
    Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-515-5p inhibits the proliferation, migration and invasion of human breast cancer cells by targeting CBX4.
    Wen LJ; Wang YS; Tan PY
    Exp Ther Med; 2021 Nov; 22(5):1328. PubMed ID: 34630682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
    Wang J; Yang K; Cao J; Li L
    Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
    Yang L; Liu S; Yang L; Xu B; Wang M; Kong X; Song Z
    Oncol Lett; 2022 May; 23(5):162. PubMed ID: 35399330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA RNF10 inhibits tumorigenicity by targeting miR-942-5p/GOLIM4 axis in breast cancer.
    Kan B; Yan G; Shao Y; Zhang Z; Xue H
    Environ Mol Mutagen; 2022 Aug; 63(7):362-372. PubMed ID: 36054164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p/ZEB2 axis.
    Qi L; Sun B; Yang B; Lu S
    Cancer Cell Int; 2021 Feb; 21(1):133. PubMed ID: 33632213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquiritigenin Blocks Breast Cancer Progression by Inhibiting Connective Tissue Growth Factor Expression via Up-Regulating miR-383-5p.
    Zhang Z; Lin J; Hu J; Liu L
    Int J Toxicol; 2022; 41(1):5-15. PubMed ID: 35045746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
    Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
    BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.
    Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
    Oncol Lett; 2022 May; 23(5):147. PubMed ID: 35350590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.